NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024.

Schmults, Chrysalyne D; Blitzblau, Rachel; Aasi, Sumaira Z; Alam, Murad; Amini, Arya; Bibee, Kristin; Bolotin, Diana; Bordeaux, Jeremy; Chen, Pei-Ling; Contreras, Carlo M; DiMaio, Dominick; Donigan, Jessica M; Farma, Jeffrey M; Ghosh, Karthik; Harms, Kelly; Ho, Alan L; Lukens, John Nicholas; Manber, Susan; Mark, Lawrence; Medina, Theresa; Nehal, Kishwer S; Nghiem, Paul; Olino, Kelly; Park, Soo; Patel, Tejesh; Puzanov, Igor; Rich, Jason; Sekulic, Aleksandar; Shaha, Ashok R; Srivastava, Divya; Thomas, Valencia; Tomblinson, Courtney; Venkat, Puja; Xu, Yaohui Gloria; Yu, Siegrid; Yusuf, Mehran; McCullough, Beth; Espinosa, Sara

Schmults, Chrysalyne D; Blitzblau, Rachel; Aasi, Sumaira Z; Alam, Murad; Amini, Arya; Bibee, Kristin; Bolotin, Diana; Bordeaux, Jeremy; Chen, Pei-Ling; Contreras, Carlo M; DiMaio, Dominick; Donigan, Jessica M; Farma, Jeffrey M; Ghosh, Karthik; Harms, Kelly; Ho, Alan L; Lukens, John Nicholas; Manber, Susan; Mark, Lawrence; Medina, Theresa; Nehal, Kishwer S; Nghiem, Paul; Olino, Kelly; Park, Soo; Patel, Tejesh; Puzanov, Igor; Rich, Jason; Sekulic, Aleksandar; Shaha, Ashok R; Srivastava, Divya; Thomas, Valencia; Tomblinson, Courtney; Venkat, Puja; Xu, Yaohui Gloria; Yu, Siegrid; Yusuf, Mehran; McCullough, Beth; Espinosa, Sara.

Affiliation

Schmults CD; Dana-Farber/Brigham and Women's Cancer Center.
Blitzblau R; Duke Cancer Institute.
Aasi SZ; Stanford Cancer Institute.
Alam M; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Amini A; City of Hope National Medical Center.
Bibee K; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Bolotin D; The UChicago Medicine Comprehensive Cancer Center.
Bordeaux J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
Chen PL; Moffitt Cancer Center.
Contreras CM; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
DiMaio D; Fred & Pamela Buffett Cancer Center.
Donigan JM; Huntsman Cancer Institute at the University of Utah.
Farma JM; Fox Chase Cancer Center.
Ghosh K; Mayo Clinic Comprehensive Cancer Center.
Harms K; University of Michigan Rogel Cancer Center.
Ho AL; Memorial Sloan Kettering Cancer Center.
Lukens JN; Abramson Cancer Center at the University of Pennsylvania.
Manber S; Publicis Health.
Mark L; Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Medina T; University of Colorado Cancer Center.
Nehal KS; Memorial Sloan Kettering Cancer Center.
Nghiem P; Fred Hutchinson Cancer Center.
Olino K; Yale Cancer Center/Smilow Cancer Hospital.
Park S; UC San Diego Moores Cancer Center.
Patel T; The University of Tennessee Health Science Center.
Puzanov I; Roswell Park Comprehensive Cancer Center.
Rich J; Siteman Cancer Center at Barnes-Jewish Hospital and Washington UniversitySchool of Medicine.
Sekulic A; Mayo Clinic Comprehensive Cancer Center.
Shaha AR; Memorial Sloan Kettering Cancer Center.
Srivastava D; UT Southwestern Simmons Comprehensive Cancer Center.
Thomas V; The University of Texas MD Anderson Cancer Center.
Tomblinson C; Vanderbilt-Ingram Cancer Center.
Venkat P; UCLA Jonsson Comprehensive Cancer Center.
Xu YG; University of Wisconsin Carbone Cancer Center.
Yu S; UCSF Helen Diller Family Comprehensive Cancer Center.
Yusuf M; O'Neal Comprehensive Cancer Center at UAB.
McCullough B; National Comprehensive Cancer Network.
Espinosa S; National Comprehensive Cancer Network.

J Natl Compr Canc Netw ; 22(1D): e240002, 2024 01.

Article de En | MEDLINE | ID: mdl-38244274

ABSTRACT

ABSTRACT

The NCCN Guidelines for Merkel Cell Carcinoma (MCC) provide recommendations for diagnostic workup, clinical stage, and treatment options for patients. The panel meets annually to discuss updates to the guidelines based on comments from expert review from panel members, institutional review, as well as submissions from within NCCN and external organizations. These NCCN Guidelines Insights focus on the introduction of a new page for locally advanced disease in the setting of clinical node negative status, entitled "Clinical N0 Disease, Locally Advanced MCC." This new algorithm page addresses locally advanced disease, and the panel clarifies the meaning behind the term "nonsurgical" by further defining locally advanced disease. In addition, the guideline includes the management of in-transit disease and updates to the systemic therapy options.

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Carcinome à cellules de Merkel Type d'étude: Diagnostic_studies / Guideline Limites: Humans Langue: En Journal: J Natl Compr Canc Netw Sujet du journal: NEOPLASIAS Année: 2024 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google